RESUMO
Objective To investigate the effect of compound sulfamethoxazole(SMZ.Co) combined with second-line drugs in the treatment of multiple drug-resistant tuberculosis(MDR-TB).Methods Eighty-five cases of MDR-TB collected in this hospital from March 2014 to December 2016 were divided into the group A,B and C group.The C group underwent the conventional secondline anti-TB treatment,on this basis the group A and B were additionally added with 0.96 g and 0.48 g SMZ.Co respectively.The clinical curative effects(such as cough,phlegm,sputum bacterial negative conversion rate and X-rays) were compared among the three groups.Results Compared with C group,the cough and phlegm rates after continuous treatment for six months in the group A and B treated by combined use of SMZ.Co were significantly decreased,the difference was statistically significant(P＜0.05),while the sputum bacterial negative conversion rate,change of lesion focus and cavity,and treatment outcome rate had no statistical difference(P＞0.05).Conclusion The application of SMZ.Co combined with second-line drugs in the treatment of MDR-TB could effectively relieve the symptom of cough and phlegm.
RESUMO
OBJECTIVE To investigate mechanisms of sulfamethoxazolel trimethoprim(SMZco) resistance in multi-drug-resistant strains of Shigella.METHODS The strains of multi-resistant Shigella were selected with K-B susceptibility method.The genes(sul1,dfrA1,dfrA5,dfrA12 and dfrA17) of SMZco resistance were detected by polymerase chain reaction(PCR).And using the DNA sequencing determined that bears the genotype.RESULTS In 20 Shigella strains the drug-resistance rate of Shigella to SMZco was 95.0%.Sul1,dfrA1,dfrA12 and dfrA17-positive rate was 15.0%,100.0%,5.0% and 0,DfrA1 positive gene sequencing showed highly homology with the sequence of GenBank.CONCLUSIONS There is a close relation of the SMZco resistance in Shigella to sul1 and dfrA1 existing.
RESUMO
Objective To evaluate the effect of allicin alone or combined with SMZco on murine toxoplasmosis by aspecific, rapid, and sensitive PCR technique. Methods 147 mice were infected with 2?10~4 tachyzoites intraperitoneallyand divided into 5 groups at random. Each group was divided into two sub-groups except an untreated group. One sub-group was used to get samples for PCR test and the other for observing the survival duration. The therapeutic grouping wasas follows: group A, a combination of allicin and SMZco administered orally for 7 days and continued by allicin alone till 21days; group B, the combination administered for 14 days and continued with allicin till 21 days; group C, allicin alone for21 days; group D, SMZco alone for 7 days; group E, untreated control. The dosage was: SMZco 400 mg/(kg?d) and al-licin 35 mg/ (kg?d). PCR test was used to detect the parasites in samples of liver and blood from infected mice at 5, 10, 15,20, 25, 30, 40 and 50 days after infection. Results Parasites were eliminated in the blood because no signal was seen inall the blood samples except for samples from group C at day 5 after infection. From day 10 after infection until the end ofthe experiment, no amplification of DNA was seen in all the samples. As for liver samples, signals were clear at day 5 postinfection. From day 10 post infection till the day 50 post-infection, parasites were still detected, but the PCR products de-creased significantly than that of day 5 post-infection. Result showed that a combination of SMZco with allicin provided asignificant protection. SMZco alone was also effective, but allicin alone was not. Conclusion When SMZco is used incombination with allicin, a much higher efficacy is received in the treatment of acute murine toxoplasmosis.